Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 38, 1889-1892, July 1, 1978]
© 1978 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schreiber, R.
Right arrow Articles by Raso, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schreiber, R.
Right arrow Articles by Raso, V.

Radioimmunoassay for the Detection and Quantitation of 5-Fluorodeoxyuridine1

Ronnye Schreiber and Vic Raso2

Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115

A sensitive radioimmunoassay for 5-fluorodeoxyuridine (FdUrd) and 5-fluoro-2'-deoxyuridine 5'-monophosphate has been developed by using antibody induced in rabbits, [3H]FdUrd, and a separation technique with nitrocellulose filters. Antibody specificity was characterized by using compounds chemically related to FdUrd and comparing their effectiveness for displacing [3H]FdUrd from the antibody-combining site. Drug levels in serum samples from patients receiving FdUrd chemotherapy were easily and rapidly determined, and the serum disappearance of the drug was followed by this method. FdUrd was also detected and quantified in urine samples. According to the antiserum used, as little as 1 to 10 pmol FdUrd were measurable.

1 This work was supported in part by NIH Grant CA 19589.

2 To whom requests for reprints should be addressed, at Division of Tumor Immunology, Sidney Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, Mass. 02115.

Received 8/31/77. Accepted 3/30/78.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1978 by the American Association for Cancer Research.